# Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

> **NCT06735534** · NA · RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 376 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **DEVICE:** FARAPULSE™ Pulsed Field Ablation System

## Key facts

- **NCT ID:** NCT06735534
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-03
- **Primary completion:** 2027-04
- **Final completion:** 2028-01
- **Target enrollment:** 376 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06735534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06735534, "Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06735534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*